These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

649 related items for PubMed ID: 28416406

  • 1. Acute Stroke Despite Dabigatran Anticoagulation Treated with Idarucizumab and Intravenous Tissue Plasminogen Activator.
    Bissig D, Manjunath R, Traylor BR, Richman DP, Ng KL.
    J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):e102-e104. PubMed ID: 28416406
    [Abstract] [Full Text] [Related]

  • 2. Intravenous Thrombolysis After Idarucizumab Application in Acute Stroke Patients-A Potentially Increased Sensitivity of Thrombi to Lysis?
    Pretnar Oblak J, Sabovic M, Frol S.
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):768-773. PubMed ID: 30527792
    [Abstract] [Full Text] [Related]

  • 3. Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan.
    Fang CW, Tsai YT, Chou PC, Chen HM, Lu CM, Tsao CR, Chen CL, Sun MC, Shih YS, Hsieh CY, Chen LA, Chen PL, Yeh JT, Li YH.
    J Stroke Cerebrovasc Dis; 2019 Mar; 28(3):815-820. PubMed ID: 30573284
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Intravenous Thrombolysis in Patients with Acute Ischemic Stroke after a Reversal of Dabigatran Anticoagulation with Idarucizumab: A Real-World Clinical Experience.
    Šaňák D, Jakubíček S, Černík D, Herzig R, Kunáš Z, Mikulík R, Ostrý S, Reif M, Rohan V, Tomek A, Veverka T.
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2479-2483. PubMed ID: 29807757
    [Abstract] [Full Text] [Related]

  • 6. Acute reversal of dabigatran with Idarucizumab for intravenous thrombolysis as acute stroke treatment.
    Meyer D, Chu F, Derry K, Hailey L.
    J Clin Neurosci; 2019 Jan; 59():355-357. PubMed ID: 30309801
    [Abstract] [Full Text] [Related]

  • 7. Thrombolytic Therapy in Severe Cardioembolic Stroke After Reversal of Dabigatran with Idarucizumab: Case Report and Literature Review.
    Ohya Y, Makihara N, Wakisaka K, Morita T, Ago T, Kitazono T, Takaba H.
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):e128-e131. PubMed ID: 29555397
    [Abstract] [Full Text] [Related]

  • 8. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany - A national case collection.
    Kermer P, Eschenfelder CC, Diener HC, Grond M, Abdalla Y, Althaus K, Berrouschot J, Cangür H, Daffertshofer M, Edelbusch S, Gröschel K, Haase CG, Harloff A, Held V, Kauert A, Kraft P, Lenz A, Müllges W, Obermann M, Partowi S, Purrucker J, Ringleb PA, Röther J, Rossi R, Schäfer N, Schneider A, Schuppner R, Seitz RJ, Szabo K, Wruck R.
    Int J Stroke; 2017 Jun; 12(4):383-391. PubMed ID: 28494694
    [Abstract] [Full Text] [Related]

  • 9. Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report.
    Agosti S, Casalino L, Rocci E, Zaccone G, Rota E.
    J Med Case Rep; 2017 Aug 15; 11(1):224. PubMed ID: 28806993
    [Abstract] [Full Text] [Related]

  • 10. Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report.
    Ohtani T, Sintoku R, Yajima T, Kaneko N.
    J Med Case Rep; 2019 Dec 26; 13(1):390. PubMed ID: 31875786
    [Abstract] [Full Text] [Related]

  • 11. Intravenous Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Stroke Patient Receiving Dabigatran Anticoagulant After Antagonization With Idarucizumab.
    Berrouschot J, Stoll A, Hogh T, Eschenfelder CC.
    Stroke; 2016 Jul 26; 47(7):1936-8. PubMed ID: 27301937
    [Abstract] [Full Text] [Related]

  • 12. Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients With Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke.
    Jin C, Huang RJ, Peterson ED, Laskowitz DT, Hernandez AF, Federspiel JJ, Schwamm LH, Bhatt DL, Smith EE, Fonarow GC, Xian Y.
    Stroke; 2018 Sep 26; 49(9):2237-2240. PubMed ID: 30354981
    [Abstract] [Full Text] [Related]

  • 13. Intravenous Fibrinolysis in Ischemic Stroke of Large Vessel after Reversing Effect of Dabigatran with Idarucizumab.
    Alvarez Bravo G, Orts Castro E, Carvalho Monteiro G, López Zuazo I.
    J Stroke Cerebrovasc Dis; 2017 Sep 26; 26(9):e192-e193. PubMed ID: 28663010
    [Abstract] [Full Text] [Related]

  • 14. Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available Evidence.
    Pikija S, Sztriha LK, Sebastian Mutzenbach J, Golaszewski SM, Sellner J.
    CNS Drugs; 2017 Sep 26; 31(9):747-757. PubMed ID: 28808918
    [Abstract] [Full Text] [Related]

  • 15. Treatment With Intravenous Alteplase for Acute Ischemic Stroke After Reversal of Dabigatran With Idarucizumab: A Case Study.
    Jala S, O'Brien E.
    J Neurosci Nurs; 2019 Feb 26; 51(1):21-25. PubMed ID: 30489421
    [Abstract] [Full Text] [Related]

  • 16. Treatment With Intravenous Alteplase for Acute Ischemic Stroke After Reversal of Dabigatran With Idarucizumab: A Case Study.
    J Neurosci Nurs; 2019 Feb 26; 51(1):E1. PubMed ID: 30614937
    [No Abstract] [Full Text] [Related]

  • 17. Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke.
    Beharry J, Waters MJ, Drew R, Fink JN, Wilson D, Campbell BCV, Parsons MW, Kleinig TJ, Wu TY.
    Stroke; 2020 May 26; 51(5):1616-1619. PubMed ID: 32208845
    [Abstract] [Full Text] [Related]

  • 18. Dabigatran Reversal With Idarucizumab Preceding Thrombolysis in an Octogenarian Patient with Chronic Kidney Disease and Acute Stroke: A Case Report.
    Laxamana LC, Co COC, Yu JRT, Mojica CV, Iboleon-Dy MAM, Domingo AMC, Ilano KCS, Macrohon-Valdez MCZ.
    Clin Ther; 2020 Sep 26; 42(9):1840-1845. PubMed ID: 32778345
    [Abstract] [Full Text] [Related]

  • 19. Spotlight on idarucizumab and its potential for the reversal of anticoagulant effects of dabigatran.
    Sié P.
    Drug Des Devel Ther; 2016 Sep 26; 10():1683-9. PubMed ID: 27274201
    [Abstract] [Full Text] [Related]

  • 20. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany-Updated series of 120 cases.
    Kermer P, Eschenfelder CC, Diener HC, Grond M, Abdalla Y, Abraham A, Althaus K, Becks G, Berrouschot J, Berthel J, Bode FJ, Burghaus L, Cangür H, Daffertshofer M, Edelbusch S, Eggers J, Gerlach R, Gröschel K, Große-Dresselhaus F, Günther A, Haase CG, Haensch CA, Harloff A, Heckmann JG, Held V, Hieber M, Kauert A, Kern R, Kerz T, Köhrmann M, Kraft P, Kühnlein P, Latta J, Leinisch E, Lenz A, Leithner C, Neumann-Haefelin T, Mäurer M, Müllges W, Nolte CH, Obermann M, Partowi S, Patzschke P, Poli S, Pulkowski U, Purrucker J, Rehfeldt T, Ringleb PA, Röther J, Rossi R, El-Sabassy H, Sauer O, Schackert G, Schäfer N, Schellinger PD, Schneider A, Schuppner R, Schwab S, Schwarte O, Seitz RJ, Senger S, Shah YP, Sindern E, Sparenberg P, Steiner T, Szabo K, Urbanek C, Sarnowksi BV, Weissenborn K, Wienecke P, Witt K, Wruck R, Wunderlich S.
    Int J Stroke; 2020 Aug 26; 15(6):609-618. PubMed ID: 31955706
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.